Quiz

Quiz: Predictors of Psoriatic Arthritis

Priyam Vora, Associate Editor

02/22/2024

© 2023 HMP Global. All Rights Reserved.

Related Content

Alexis Ogdie

Conference Coverage

Alexis Ogdie, MD, on New and Emerging Therapies for Psoriatic Arthritis

11/05/2025

Alexis Ogdie, MD

Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.

Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.

Dr Ogdie provides updates on new...

11/05/2025

Rheumatology & Arthritis

Laura Coates

Conference Coverage

Laura Coates, MBChB, on Progression to Psoriatic Arthritis from Psoriasis

11/03/2025

Laura Coates, MBChB

Dr Coates discusses her presentation at ACR Convergence on a study that found the risk of developing psoriatic arthritis was lowest among patients with psoriasis who were treated with IL-17 inhibitors compared to those treated with IL-23,...

Dr Coates discusses her presentation at ACR Convergence on a study that found the risk of developing psoriatic arthritis was lowest among patients with psoriasis who were treated with IL-17 inhibitors compared to those treated with IL-23,...

Dr Coates discusses her...

11/03/2025

Rheumatology & Arthritis

Sofia Ramiro

Conference Coverage

Sofia Ramiro, MD, on Differences in Structural Spinal Lesions in Early axSpAand nonaxial SpA

10/28/2025

Sofia Ramiro, MD

Dr Ramiro reviews her presentation at ACR Convergence on the SPACE cohort study of the difference in structural lesions of the spine as assessed on radiographs and on MRI between patients with early axial SPA and patients with nonaxial SpA...

Dr Ramiro reviews her presentation at ACR Convergence on the SPACE cohort study of the difference in structural lesions of the spine as assessed on radiographs and on MRI between patients with early axial SPA and patients with nonaxial SpA...

Dr Ramiro reviews her...

10/28/2025

Rheumatology & Arthritis

Paras Karmacharya

Conference Coverage

Paras Karmacharya, MD, on Multimorbidity Clusters in axSpA, PsA, and PsO

10/28/2025

Paras Karmacharya, MD

Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...

Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...

Dr Karmacharya reviews his...

10/28/2025

Rheumatology & Arthritis

Popular Articles

Sponsored Video

Cytokines and the Future of Rheumatology

04/30/2024

In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.

In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.

In part 1 of this video series,...

04/30/2024

Rheumatology & Arthritis

News

Meta-Analysis Finds Robust Evidence Supporting Upadacitinib for axSpA

09/18/2024

Jolynn Tumolo

Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.

Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.

Upadacitinib was associated with...

09/18/2024

Rheumatology & Arthritis

News

Work Productivity Among Patients With PsA Treated With DMARDS

06/19/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...

The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.

The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.

The systematic review and...

06/19/2024

Rheumatology & Arthritis

News

Disease Burden of Occupations on Patients With PsA

10/18/2024

Jessica Garlewicz

More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.

More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.

More study is needed to gain...

10/18/2024

Rheumatology & Arthritis

News

Treat-to-Target Approach in RA Found “Suboptimal”

08/14/2024

Rebecca Mashaw

A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.

A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.

A systematic review sought to...

08/14/2024

Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

SPONSORED

Axial Involvement in SpA, Chapter 1

04/26/2022

Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.

Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.

Ethan Craig, MD, MPH, discusses...

04/26/2022

Rheumatology & Arthritis